Loading stock data…
Loading stock data…
US$30.59
Get one email when LBRX crosses your level. Checked every 15 minutes during market hours.
▼ -1.57 (-4.88%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
Healthcare · Biotechnology
LB Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company specializing in the development of novel therapies for neuropsychiatric diseases, with a particular emphasis on conditions such as schizophrenia and bipolar depression. The company’s primary focus lies in advancing its lead product candidate, LB-102, a chemically modified derivative of amisulpride—an established second-generation antipsychotic. LB-102 is designed to offer an improved therapeutic profile, aspiring to become the…
lbpharma.us4 strong buy · 8 buy · 1 hold · 0 sell · 0 strong sell (13 analysts, 2026-07-01)
4 strong buy · 7 buy · 1 hold · 0 sell · 0 strong sell (12 analysts, 2026-06-01)
4 strong buy · 7 buy · 1 hold · 0 sell · 0 strong sell (12 analysts, 2026-05-01)
4 strong buy · 5 buy · 1 hold · 0 sell · 0 strong sell (10 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-04-21 | 1.52 | 1.78 | ✓ Beat |
| 2026-03-26 | -0.32 | -0.45 | ✗ Miss |
| 2026-01-23 | 1.61 | 1.87 | ✓ Beat |
| 2025-11-25 | 3.41 | 1.16 | ✗ Miss |
| 2025-11-06 | -0.28 | -0.61 | ✗ Miss |
Companies in the same industry, via Finnhub
RSI (14-day)
44.8
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
0.67
Bearish momentumMACD below its signal line (0.94).
50-day average
30.35
Price aboveShort-term trend reference.
200-day average
23.69
Price aboveLong-term trend reference.
Daily values · indicators are descriptive, not trading advice